Kotak on Pharma: Believes that Jan Aushadhi can dent the growth prospects of branded pharma companies and de-rating could even be in scope.
Source : LearningEleven
Subscribe To Our Free Newsletter |
Kotak on Pharma: Believes that Jan Aushadhi can dent the growth prospects of branded pharma companies and de-rating could even be in scope.
Source : LearningEleven
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!